Picture of Intra-Cellular Therapies logo

ITCI — Intra-Cellular Therapies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Intra-Cellular Therapies Reports Third Quarter Results

Nov 3 (Reuters) - Intra-Cellular Therapies Inc  ITCI.O :
    * Q3 REVENUE $71.9 MILLION
    * INTRA-CELLULAR THERAPIES REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * QTRLY LOSS PER SHARE $0.57
    * Q3 EARNINGS PER SHARE VIEW $-0.81, REVENUE VIEW $66.0
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXbkpKdg 
Further company coverage:  ITCI.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Intra-Cellular Therapies

See all news